Physician

Alex Fridman, M.D.

According to 2025 Medicare claims, Alex Fridman, M.D. (NPI: 1902018385) practices internal medicine in the Los Angeles-Long Beach-Glendale, CA market, with the plurality of this provider's patient population coming from Los Angeles, CA. This provider has primary practice location at 91303-9998.

Fridman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 20 traditional Medicare patients, billed 24 HCPCS/CPT codes, and received $1,538 in Medicare payments. Part D data shows 1,115 prescription claims across 578 beneficiaries totaling $79,054 in drug costs, led by Xarelto (Rivaroxaban). 2023 DME data shows 31 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $1,523 to $1,538. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $17,902 and ending at $79,054. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$32K$64K2015 Medicare payment: $1,523 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $794 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,504 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $63,914 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $10,255 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,538 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151643$1,523
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
20201116$794
20212125$1,504
2022266967$63,914
202397158$10,255
20242024$1,538

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$339K$678K2015 Drug cost: $17,902 (USD; Tot_Drug_Cst)2016 Drug cost: $38,546 (USD; Tot_Drug_Cst)2017 Drug cost: $212,127 (USD; Tot_Drug_Cst)2018 Drug cost: $106,637 (USD; Tot_Drug_Cst)2019 Drug cost: $102,110 (USD; Tot_Drug_Cst)2020 Drug cost: $123,814 (USD; Tot_Drug_Cst)2021 Drug cost: $166,864 (USD; Tot_Drug_Cst)2022 Drug cost: $387,048 (USD; Tot_Drug_Cst)2023 Drug cost: $678,203 (USD; Tot_Drug_Cst)2024 Drug cost: $79,054 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201551362$17,902
2016160604$38,546
20178834,290$212,127
20188102,533$106,637
20197492,214$102,110
20205572,615$123,814
20218323,407$166,864
20221,0713,620$387,048
20238424,290$678,203
20245781,115$79,054

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$232$4632023 Medicare payment: $463 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/R31$463
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Part B summary data is connected for 2024, but public code-level payment amounts are not available, so a Top 5 by total payments cannot be shown.

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
XareltoRivaroxaban19476$7,574
BreynaBudesonide/Formoterol Fumarate131,110$4,542
LidocaineLidocaine23690$2,388
ArexvyRsvpref3 Antigen/As01e/Pf1111$1,617
Terazosin HclTerazosin Hcl201,649$1,331

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Alex Fridman, M.D.?

Tedicare shows public-source Medicare data for Alex Fridman, M.D. (NPI 1902018385), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alex Fridman, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alex Fridman, M.D.?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does Alex Fridman, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.